StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
6850.T$1616.00-1.76%
Fair $1616.00+0.0%

6850.T

Chino Corporation

Technology / Scientific & Technical InstrumentsTokyo

$1616.00

-29.00 (-1.76%)

Fairly Valued+0.0%Fair Value $1616.00Fund rank 30/100 · Data gapFallback financials|
SA 62/B
F-Score: 8/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 23%

FCF escenarios

weak_data · normalized FCF $1.0B · quality 51.7/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 31/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

62/100

B

Piotroski

8/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 6850.TLocal privado en este navegador · Chino Corporation
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$26.9B

P/E

13.4x

↓

EV/EBITDA

5.4x

↓

ROE

9.1%

↑

Gross Margin

31.9%

↓

Debt/Equity

0.12

↓
52-Week Range$1616
$1082$1874

TradingView lightweight chart

6850.T price, volumen y niveles de valoración

Último $1,616Periodo +212.3%
Fair value: $1,616

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+10.2%

FCF CAGR

+20.8%

FCF margin

5.8%

FCF / Net income

0.86x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $29.33B · net income $1.99B · FCF $1.71B

2022-FY → 2025-FY

Gross margin

31.9%-0.4% pts

Operating margin

9.8%+3.0% pts

Net margin

6.8%+2.0% pts

FCF margin

5.8%+1.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$29.33B$29.33B$27.43B$23.79B$21.91B
Net Income$1.99B$1.99B$1.76B$1.54B$1.05B
EBITDA$4.04B$4.04B$3.57B$3.10B$2.52B
EPS117.16117.16103.4490.6162.03
Gross Margin31.9%31.9%30.6%33.1%32.3%
Operating Margin9.8%9.8%7.9%8.5%6.9%
Net Margin6.8%6.8%6.4%6.5%4.8%
Balance Sheet
Debt/Equity0.120.120.150.180.13
Current Ratio3.043.04———
Cash Flow
Free Cash Flow$1.71B$1.71B$-1.34B$1.05B$970.0M
Returns
ROE9.1%9.1%8.7%8.2%6.0%
Valuation
P/E13.4213.4212.5412.0313.17
EV/EBITDA5.435.434.974.103.48
P/B1.251.251.090.980.79
Growth & Yield
Revenue Growth6.9%6.9%15.3%8.6%—
EPS Growth13.3%13.3%14.2%46.1%—
Dividend Yield3.0%3.0%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

7.0%

razonable

EPS terminal req.

$143.39

Spread vs growth

6.3%

5Y implied EPS CAGR

8.2%

razonable

EPS terminal req.

$173.51

Spread vs growth

5.1%

10Y implied EPS CAGR

9.1%

razonable

EPS terminal req.

$279.43

Spread vs growth

4.2%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +49.7%

Total return

+49.7%

Start / end P/E

10.6x → 13.8x

EPS bridge

103.44 → 117.16

Residual

+3.9%

EPS growth+13.3%
Multiple rerating+29.5%
Dividend+3.0%
Residual / FX / buybacks / cross-term+3.9%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.